Vischer advises Medartis on its stake expansion in KeriMedical 

Basel-based orthopedic firm, Medartis, has successfully completed the acquisition of an additional 18% stake in Geneva-based implant manufacturer, KeriMedical, for approximately CHF 18 million. This deal will raise Medartis’ stake to 47%, further cementing the company’s commitment to becoming a one-stop-shop for hand and wrist solutions, as well as increasing its presence in extremity joint replacement.

Vischer advised Medartis on legal and tax issues related to the acquisition of an additional stake. The Vischer team includes Christian Wyss (partner, corporate/m&a, pictured), Pauline Pfirter (senior associate, corporate/m&a), Luzius Zumstein (managing associate, corporate/m&a), Adrian Briner (managing associate, tax) and Oerjan Wickart (junior associate, corporate/m&a). 

By combining their respective relationships with leading professionals and expertise in development, regulatory affairs, and innovation, both companies aim to leverage this partnership for mutual benefit. KeriMedical’s founding shareholders will still retain control of the company under the new agreement. The acquisition is expected to be completed by the end of the first quarter or early in the second quarter, with the purchase price being paid through existing cash on hand, credit facilities, and/or additional financing options.